VERTEX PHARMACEUTICALS INC (VRTX)

US92532F1003 - Common Stock

391.5  -1.98 (-0.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
7.574B
22.06%		8.931B
17.91%		9.869B
10.51%		10.928B
10.73%
EBITDA
YoY % growth
2.908B
-1.96%		4.469B
53.69%		4.013B
-10.19%		5.184B
29.17%		N/AN/AN/AN/A
EBIT
YoY % growth
2.782B
-2.60%		4.32B
55.29%		3.832B
-11.30%		4.954B
29.28%
Operating Margin
36.73%48.38%38.83%45.33%
EPS
YoY % growth
13.02
26.16%		14.89
14.36%		15.22
2.22%		17.11
12.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		4.13
35.32%
Revenue
Q2Q % growth		2.623B
10.45%
EBITDA
Q2Q % growth		1.299BN/AN/AN/AN/A
EBIT
Q2Q % growth		1.198B
53.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 4.20
11.70%		4.180.020.36%
Q3 2023
Q2Q % growth		 4.08
1.75%		4.050.030.66%
Q2 2023
Q2Q % growth		 3.89
8.06%		3.96-0.07-1.75%
Q1 2023
Q2Q % growth		 3.05
-13.35%		3.06-0.01-0.21%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 2.518B
9.34%		2.564B-46.3M-1.81%
Q3 2023
Q2Q % growth		 2.484B
6.39%		2.55B-66.5M-2.61%
Q2 2023
Q2Q % growth		 2.493B
13.52%		2.468B25.2M1.02%
Q1 2023
Q2Q % growth		 2.375B
13.22%		2.384B-9.2M-0.39%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.65% -2.76% 0.23% 1.46%
Revenue0% 2.34% 0% 1.46%